Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Oct 2026: Chinese technology group Midea completed the acquisition of a controlling stake in Esaote. Esaote said it will operate independently within Midea Healthcare, headquartered in Genoa, with its CEO remaining in post.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches or cyber incidents involving Esaote found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
Mar 2025: Esaote began a US FDA Class 2 recall of five E 3-12 endocavity ultrasound probes after identifying a weakness in the probe body that could let liquid leak near the cable; the recall is listed as completed.
Contract delivery, go-lives, terminations and disputes.
No notable contract go-lives, disputes or terminations involving Esaote found in HSH's search of the last 24 months.